BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Nonalcoholic fatty liver disease
1
Phase III, multicenter, randomized, double-blind, placebo-controlled study of norursodeoxycholic acid in metabolic dysfunction-associated steatotic liver disease patients
12/26/2025 10:27:34 AM | Browse: 38 | Download: 114
2
Clinical and biological significance of the relationship between gut microbiota and liver disease
12/26/2025 10:27:30 AM | Browse: 54 | Download: 88
3
Quick glance at 'metabolic dysfunction associated steatotic liver disease' therapeutics: Targets, trials, and trends
12/5/2025 11:28:02 AM | Browse: 37 | Download: 88
4
Essential phospholipids and enzyme-based staging in nonalcoholic fatty liver disease: A call to action
11/27/2025 7:53:52 AM | Browse: 24 | Download: 94
5
Link between type 2 diabetes mellitus and hepatocellular carcinoma
7/25/2025 12:09:46 PM | Browse: 85 | Download: 225
6
Construction of a community-based primary screening and hospital-based confirmatory screening pathway in pediatric nonalcoholic fatty liver disease
7/24/2025 7:47:20 AM | Browse: 70 | Download: 258
7
Risk of hepatocellular carcinoma according to body mass index and waist circumference in nonalcoholic fatty liver disease
6/13/2025 1:39:34 PM | Browse: 109 | Download: 571
8
Diagnostic accuracy of noninvasive steatosis biomarkers with magnetic resonance imaging proton density fat fraction as gold standard
5/26/2025 7:26:12 AM | Browse: 98 | Download: 674
9
Role of autoimmune phenomena in nonalcoholic fatty liver disease: Insights and limitations
3/26/2025 4:06:58 AM | Browse: 121 | Download: 381
10
Non-alcoholic fatty liver disease and drug induced liver injury: A metabolic storm waiting to happen
3/26/2025 4:06:56 AM | Browse: 127 | Download: 461
11
Research hotspots and trends in gut microbiota and nonalcoholic fatty liver disease: A bibliometric study
1/6/2025 8:47:56 AM | Browse: 164 | Download: 479
12
What is the role of nonalcoholic fatty liver disease in pulmonary carcinoma development?
12/30/2024 9:49:59 AM | Browse: 142 | Download: 557
13
Revolutionizing the understanding of liver disease: Metabolism, function and future
11/29/2024 2:50:19 PM | Browse: 155 | Download: 663
14
Evaluation of autoimmune phenomena in patients with nonalcoholic fatty liver disease on the basis of liver pathology
11/29/2024 2:50:19 PM | Browse: 163 | Download: 883
15
Influence of nonalcoholic fatty liver disease on the therapeutic effect of nucleoside (acid) analogs for hepatitis B virus
11/29/2024 2:50:18 PM | Browse: 155 | Download: 851
16
Effect of Dendrobium nobile powder combined with conventional therapy on mild to moderate fatty liver
11/13/2024 10:10:51 AM | Browse: 45 | Download: 239
17
Potential of traditional Chinese medicine in the treatment of nonalcoholic fatty liver disease: A promising future
10/31/2024 10:42:49 AM | Browse: 169 | Download: 592
18
Cardiovascular and Nonalcoholic Fatty Liver Disease: Sharing Common Ground through SIRT1 Pathways
10/31/2024 8:01:10 AM | Browse: 81 | Download: 455
19
Regression of hepatic fibrosis after pharmacological therapy for nonalcoholic steatohepatitis
10/25/2024 3:02:15 AM | Browse: 164 | Download: 606
20
Role of cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon genes pathway in diabetes and its complications
9/26/2024 8:51:02 AM | Browse: 73 | Download: 461
21
Blood cell counts and nonalcoholic fatty liver disease: Evidence from Mendelian randomization analysis
8/21/2024 11:22:32 PM | Browse: 76 | Download: 530
22
Fanlian Huazhuo Formula alleviates high-fat diet-induced non-alcoholic fatty liver disease by modulating autophagy and lipid synthesis signaling pathway
8/9/2024 12:51:13 PM | Browse: 120 | Download: 796
23
Prevalence of nonalcoholic fatty liver disease in patients with hepatitis B: A meta-analysis
7/17/2024 5:55:51 AM | Browse: 167 | Download: 808
24
Alanine aminotransferase as a risk marker for new-onset metabolic dysfunction-associated fatty liver disease
7/1/2024 7:39:37 AM | Browse: 210 | Download: 845
25
Scale offers the possibility of identifying adherence to lifestyle interventions in patients with non-alcoholic fatty liver disease
7/1/2024 7:39:37 AM | Browse: 185 | Download: 675
26
Alanine aminotransferase predicts incident steatotic liver disease of metabolic etiology. Long life to the old biomarker !
6/25/2024 10:41:21 AM | Browse: 155 | Download: 707
27
Mapping the global research landscape on nonalcoholic fatty liver disease and insulin resistance: A visualization and bibliometric study
6/20/2024 3:42:22 AM | Browse: 235 | Download: 894
28
Validation of adherence prediction system for lifestyle interventions in nonalcoholic fatty liver disease
5/27/2024 9:35:51 AM | Browse: 246 | Download: 707
29
Impact of lifestyle interventions on pathogenesis of nonalcoholic fatty liver disease
5/27/2024 9:35:51 AM | Browse: 219 | Download: 695
30
Transient elastography with controlled attenuation parameter for the diagnosis of colorectal polyps in patients with nonalcoholic fatty liver disease
4/16/2024 7:57:40 AM | Browse: 103 | Download: 854
31
Necroptosis contributes to non-alcoholic fatty liver disease pathoetiology with promising diagnostic and therapeutic functions
4/12/2024 4:45:44 PM | Browse: 242 | Download: 724
32
Influence of nonalcoholic fatty liver disease on response to antiviral treatment in patients with chronic hepatitis B: A meta-analysis
3/27/2024 1:28:19 PM | Browse: 235 | Download: 977
33
Investigating the causal associations between five anthropometric indicators and nonalcoholic fatty liver disease: Mendelian randomization study
3/1/2024 2:45:04 AM | Browse: 179 | Download: 817
34
Circulating microRNA expression and nonalcoholic fatty liver disease in adolescents with severe obesity
1/26/2024 7:56:29 AM | Browse: 381 | Download: 1291
35
Metabolic disease and the liver: A review
1/23/2024 9:31:45 AM | Browse: 376 | Download: 1013
36
Potential therapeutic targets for nonalcoholic fatty liver disease: Glucagon-like peptide 1
12/27/2023 5:42:53 AM | Browse: 292 | Download: 1096
37
Multifunctional roles of inflammation and its causative factors in primary liver cancer: A literature review
12/25/2023 6:03:15 AM | Browse: 344 | Download: 1148
38
Case-control analysis of venous thromboembolism risk in non-alcoholic steatohepatitis diagnosed by transient elastography
12/6/2023 8:08:49 AM | Browse: 353 | Download: 1337
39
Global burden of cirrhosis and other chronic liver diseases due to nonalcoholic fatty liver disease, 1990-2019
11/24/2023 6:10:12 AM | Browse: 365 | Download: 1403
40
Global trends and hotspots of treatment for nonalcoholic fatty liver disease: A bibliometric and visualization analysis (2010-2023)
9/25/2023 9:07:43 AM | Browse: 345 | Download: 1081
41
Huangqin decoction alleviates lipid metabolism disorders and insulin resistance in nonalcoholic fatty liver disease by triggering Sirt1/NF-κB pathway
8/18/2023 10:08:22 AM | Browse: 392 | Download: 1597
42
Antagonizing adipose tissue-derived exosome miR-103-hepatocyte phosphatase and tensin homolog pathway alleviates autophagy in non-alcoholic steatohepatitis: A trans-cellular crosstalk
8/2/2023 9:29:03 AM | Browse: 325 | Download: 1280
43
F-box only protein 2 exacerbates non-alcoholic fatty liver disease by targeting the hydroxyl CoA dehydrogenase alpha subunit
7/26/2023 11:55:37 AM | Browse: 265 | Download: 1388
44
Role of vascular endothelial growth factor B in nonalcoholic fatty liver disease and its potential value
6/25/2023 2:17:08 PM | Browse: 353 | Download: 1164
45
Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease
5/24/2023 9:31:05 AM | Browse: 395 | Download: 1182
46
Mitochondrial carnitine palmitoyltransferase-II dysfunction: A possible novel mechanism for nonalcoholic fatty liver disease in hepatocarcinogenesis
3/28/2023 12:59:29 PM | Browse: 277 | Download: 975
47
Emerging role of engineered exosomes in nonalcoholic fatty liver disease
3/22/2023 11:20:34 AM | Browse: 407 | Download: 1359
48
Microbiome-liver crosstalk: A multihit therapeutic target for liver disease
3/17/2023 6:20:53 AM | Browse: 393 | Download: 1133
49
Outcomes of gout in patients with cirrhosis: A national inpatient sample-based study
2/24/2023 1:35:50 PM | Browse: 288 | Download: 1019
50
Baseline hepatocyte ballooning is a risk factor for adverse events in patients with chronic hepatitis B complicated with nonalcoholic fatty liver disease
2/24/2023 1:35:50 PM | Browse: 442 | Download: 1382
Write to the Help Desk
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345